Skip to content

Real world study of recurrent pregnancy loss in China

Real world study of recurrent pregnancy loss in China

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000039414
Enrollment
Unknown
Registered
2020-10-27
Start date
2020-10-30
Completion date
Unknown
Last updated
2021-02-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Recurrent pregnancy loss

Interventions

No pregnancy group with recurrent pregnancy loss:Immunosuppressive drugs were used according to the test indexes
Pregnancy group with repeated pregnancy loss:Immunosuppressive drugs were used according to the test indexes
No pregnancy group with pregnancy loss one:Immunosuppressive drugs were used according to the test indexes
Pregnancy group with pregnancy loss one:Immunosuppressive drugs were used according to the test indexes

Sponsors

The Second hospital of Lanzhou University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Patients who know and sign the informed consent; 2. Female aged 20-45 years; 3. The subjects who had one or more pregnancy failures before 24 weeks of gestation; 4. Patients willing to follow the doctor's advice; 5. Patients who plan to visit the hospital for a long time.

Exclusion criteria

Exclusion criteria: 1. Participants in other intervention studies at the same time; 2. People with reading or hearing impairment can not fill in the questionnaire; 3. All trophoblastic diseases, ectopic pregnancy, voluntary abortion and drug abortion were not included in the category of recurrent pregnancy loss.

Design outcomes

Primary

MeasureTime frame
aCL-IgM;aCL-IgA;aCL-IgG;ß2GPI-IgG;ß2GPI-IgA;ß2GPI-IgM;LA1;LA2;LA1/LA2;aPC;aPS;aD1;aPE;aANXA2;aANXA5;aVim/CL;PT-IgM;PT-IgG;PS-IgM;PS-IgG;PC;PS;ANA;CD56NK;Treg;TH1/TH2;AMH;HCY;VitD;

Countries

China

Contacts

Public ContactWang Fang

The Second Hospital of Lanzhou University

ery_fwang@lzu.edu.cn+86 13919302888

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 8, 2026